Novel molecular and metabolic aspects in osteosarcoma.

Tsiambas, Evangelos; Fotiades, Panagiotis P; Sioka, Chrissa; Kotrotsios, Dimitrios; Gkika, Evangelia; Fotopoulos, Andreas; Mastronikolis, Stylianos N; Armata, Ilianna E; Giotakis, Evangelos; Ragos, Vasileios

Tsiambas, Evangelos; Fotiades, Panagiotis P; Sioka, Chrissa; Kotrotsios, Dimitrios; Gkika, Evangelia; Fotopoulos, Andreas; Mastronikolis, Stylianos N; Armata, Ilianna E; Giotakis, Evangelos; Ragos, Vasileios.

Affiliation

Tsiambas E; Department of Immunohistochemistry & Molecular Biology, 401 GAH, Athens, Greece.

J BUON ; 22(6): 1595-1598, 2017.

Article in En | MEDLINE | ID: mdl-29332359

Subject(s)

Bone Neoplasms/genetics; Molecular Targeted Therapy; Neoplasm Proteins/genetics; Osteosarcoma/genetics; Tumor Suppressor Proteins/genetics; Antibodies, Monoclonal/therapeutic use; Bone Neoplasms/diagnostic imaging; Bone Neoplasms/metabolism; Bone Neoplasms/therapy; Fluorodeoxyglucose F18/therapeutic use; Gene Expression Regulation, Neoplastic/genetics; Humans; Neoplasm Metastasis; Neoplasm Proteins/metabolism; Oncogenes/genetics; Osteosarcoma/diagnostic imaging; Osteosarcoma/metabolism; Osteosarcoma/therapy; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors/therapeutic use; Tumor Suppressor Proteins/metabolism

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Bone Neoplasms / Osteosarcoma / Tumor Suppressor Proteins / Molecular Targeted Therapy / Neoplasm Proteins Limits: Humans Language: En Year: 2017 Type: Article

Search on Google

XML

PubMed Links